Acadia Healthcare financials
$28.04+0.47%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $865.8M | $828.8M | $821.5M | $851.6M | $869.2M | $770.5M | $774.2M | $815.6M | $796.0M | $768.1M | $742.8M | $750.3M |
| Gross profit | $865.8M | $828.8M | $821.5M | $851.6M | $869.2M | $770.5M | $774.2M | $815.6M | $796.0M | $768.1M | $742.8M | $750.3M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | $80.4M | $48.1M | -$123.6M | $76.6M | $140.9M | $43.9M | $85.4M | $128.5M | $136.6M | $128.9M | $123.9M | -$259.9M |
| Net income | $10.9M | $4.1M | -$1.18B | $36.2M | $30.1M | $8.4M | $32.6M | $68.1M | $78.5M | $76.4M | $57.7M | -$217.7M |
| Net margin | 1.3% | 0.5% | −143.3% | 4.3% | 3.5% | 1.1% | 4.2% | 8.4% | 9.9% | 9.9% | 7.8% | −29.0% |
| Diluted EPS | $0.12 | $0.05 | $-13.12 | $0.40 | $0.33 | $0.09 | $0.35 | $0.74 | $0.85 | $0.83 | $0.64 | $-2.39 |
| EBITDA | $138.2M | $136.3M | $93.4M | $167.0M | $191.3M | $125.5M | $143.0M | $184.8M | $178.8M | $165.3M | $125.0M | $167.7M |
| Operating cash flow | $162.1M | $61.5M | -$86.3M | $73.2M | $133.5M | $11.5M | $116.7M | $163.1M | $171.1M | -$321.3M | $116.3M | $137.9M |
| Free cash flow | $123.5M | -$15.0M | -$179.5M | -$63.0M | -$34.2M | -$163.2M | -$86.8M | -$27.1M | $16.9M | -$463.7M | -$22.4M | $9.8M |
| Diluted shares | 91.4M | 90.9M | 89.8M | 90.6M | 90.4M | 92.0M | 92.0M | 92.2M | 92.0M | 92.0M | 89.7M | 91.2M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $171.3M | $158.5M | $133.2M | $118.7M | $131.4M | $91.2M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $2.41B | $2.53B | $2.50B | $2.31B | $2.27B | $2.20B |
| Total assets | $5.55B | $5.55B | $5.53B | $6.41B | $6.31B | $6.15B |
| Total liabilities | $3.35B | $3.38B | $3.39B | $3.12B | $3.08B | $2.97B |
| Shareholders' equity | $1.98B | $1.96B | $1.95B | $3.12B | $3.08B | $3.04B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology